ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$18.75 USD
-0.39 (-2.04%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $18.76 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/6/24 |
---|---|
Current Quarter | 0.16 |
EPS Last Quarter | 0.10 |
Last EPS Surprise | 150.00% |
ABR | 1.70 |
Earnings ESP
|
-17.46% |
---|---|
Current Year | 0.58 |
Next Year | 1.04 |
EPS (TTM) | -0.01 |
P/E (F1) | 33.17 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 234.90M | 251.73M | 953.13M | 1.05B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 237.00M | 256.00M | 965.85M | 1.09B |
Low Estimate | 233.00M | 247.80M | 942.40M | 1.02B |
Year ago Sales | 165.24M | 211.70M | 726.44M | 953.13M |
Year over Year Growth Est. | 42.16% | 18.91% | 31.21% | 10.36% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.16 | 0.13 | 0.58 | 1.04 |
# of Estimates | 8 | 7 | 10 | 9 |
Most Recent Consensus | 0.15 | 0.15 | 0.38 | 0.74 |
High Estimate | 0.26 | 0.24 | 0.85 | 1.66 |
Low Estimate | 0.09 | -0.02 | 0.38 | 0.67 |
Year ago EPS | 0.01 | -0.40 | -0.37 | 0.58 |
Year over Year Growth Est. | 1,500.00% | 132.50% | 256.76% | 79.64% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 1 |
Down Last 60 Days | 2 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.16 | 0.13 | 0.58 | 1.04 |
7 Days Ago | 0.16 | 0.13 | 0.58 | 1.04 |
30 Days Ago | 0.16 | 0.13 | 0.58 | 1.04 |
60 Days Ago | 0.16 | 0.14 | 0.57 | 1.01 |
90 Days Ago | 0.20 | 0.19 | 0.62 | 1.17 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.13 | 0.15 | 0.47 | 0.94 |
Zacks Consensus Estimate | 0.16 | 0.13 | 0.58 | 1.04 |
Earnings ESP | -17.46% | 10.33% | -19.41% | -10.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.10 | 0.28 | -0.40 | 0.01 | NA |
Estimate | 0.04 | 0.32 | -0.43 | -0.12 | NA |
Difference | 0.06 | -0.04 | 0.03 | 0.13 | 0.05 |
Surprise | 150.00% | -12.50% | 6.98% | 108.33% | 63.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more